Serum Malondialdehyde as a Biomarker of Oxidative Stress in Patients with Primary Ocular Carcinoma: Impact on Response to Chemotherapy

Rajendra P Maurya, Manish Prajapat, V. P. Singh, Meghna Roy, Ravina Todi, Sanjay Kumar Bosak, Sunit K. Singh, Sunil Choudhary, Anil Kumar, Sunil R MorekarClinical 2021 · DOI

Abstract

The serum MDA level is a potential biomarker in primary ocular carcinoma to assess oxidative stress and its impact on response to chemotherapy.
BibTeX
@inproceedings{maurya2021serum,
  author = {Rajendra P Maurya and Manish Prajapat and V. P. Singh and Meghna Roy and Ravina Todi and Sanjay Kumar Bosak and Sunit K. Singh and Sunil Choudhary and Anil Kumar and Sunil R Morekar},
  title = {{Serum Malondialdehyde as a Biomarker of Oxidative Stress in Patients with Primary Ocular Carcinoma: Impact on Response to Chemotherapy}},
  booktitle = {Clinical},
  year = {2021},
  doi = {10.2147/opth.s287747},
}

Loading related content...

Figure